Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 321-330 of 2932 for cancer

Edit search filters
  1. Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Expanded Access Ga68 PSMA PET Imaging

    Rochester, MN

  3. Testing The Role Of FDG-PET/CT To Predict Response To Therapy Prior To Surgery For HER2-positive Breast Cancer, The DIRECT Trial

    Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Rochester, MN

  4. Induction Pembrolizumab And Chemotherapy Followed By Pembrolizumab Before Chemoradiation And Pembrolizumab Maintenance Compared To Standard Chemoradiation With Pembrolizumab Followed By Pembrolizumab Maintenance In High-Risk Cervical Cancer

    Rochester, MN

  5. A Study To Evaluate Tazemetostat And Pembrolizumab To Treat Advanced Urothelial Carcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Long Term Follow-Up Of Subjects Exposed To GSK3377794

    Jacksonville, FL, Rochester, MN

  7. Rifaximin For The Treatment Of Gastrointestinal Toxicities Related To Pertuzumab-Based Therapy In Patients With Stage I-III HER2 Positive Breast Cancer

    Jacksonville, FL

  8. National Wilm's Tumor Study Late Effects

    Rochester, MN

  9. MMRC Horizon One Adaptive Platform Trial Evaluating Therapies In RRMM

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study Of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared To Pembrolizumab Alone In People With Previously Untreated Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer